Camber Capital Management LP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.

Quarter-by-quarter ownership
Camber Capital Management LP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$96,976
+111.7%
800,000
+100.0%
3.20%
+114.2%
Q2 2023$45,808
-55.7%
400,000
-46.7%
1.49%
-53.1%
Q1 2023$103,373
-36.2%
750,000
-40.0%
3.18%
-42.8%
Q4 2022$161,975
-99.9%
1,250,000
-16.7%
5.56%
+9.4%
Q3 2022$165,810,000
+19.6%
1,500,000
-18.9%
5.08%
-15.6%
Q2 2022$138,676,000
+29.1%
1,850,000
+34.5%
6.02%
+54.9%
Q1 2022$107,415,000
+44.6%
1,375,000
+66.7%
3.88%
+52.2%
Q4 2021$74,291,000
+60.7%
825,000
+65.0%
2.55%
+79.3%
Q3 2021$46,240,000
-32.2%
500,000
+25.0%
1.42%
-40.5%
Q4 2020$68,196,000
-42.9%
400,000
-52.9%
2.39%
-24.0%
Q3 2020$119,366,000
+86.1%
850,000
+112.5%
3.15%
-14.2%
Q2 2020$64,136,000
-9.6%
400,000
-44.8%
3.67%
-13.4%
Q1 2020$70,920,000
-8.4%
725,000
+20.8%
4.24%
+7.5%
Q4 2019$77,424,000
+37.1%
600,000
-20.0%
3.94%
+32.6%
Q3 2019$56,490,000
-25.6%
750,000
+50.0%
2.97%
-16.1%
Q2 2019$75,975,000
+27.5%
500,0000.0%3.54%
+19.3%
Q1 2019$59,595,000
+56.0%
500,000
+42.9%
2.97%
+63.9%
Q4 2018$38,196,000
+128.8%
350,000
+16.7%
1.81%
+121.8%
Q4 2017$16,692,000
-73.7%
300,000
-78.6%
0.82%
-79.7%
Q3 2017$63,504,000
+44.9%
1,400,000
+7.7%
4.02%
+88.6%
Q2 2017$43,823,000
+9.7%
1,300,000
-3.7%
2.13%
+31.6%
Q1 2017$39,960,000
+69.2%
1,350,000
+170.0%
1.62%
-34.5%
Q3 2013$23,615,000500,0002.48%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders